Catalog #: 92003
The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term.
The Maxim HIV-1 LAg-Avidity DBS EIA uses US CDC developed technology and is designed for surveillance purposes such as estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence populations so that prevention research, vaccine trials, and resources are most appropriately utilized.
This product is for research use only and is not intended for use in diagnostic procedures.
Additional information
What's Included
Refrigerator Pack
- Recominant gp41 HIV-1 Antigen Coated Microwell Plate (2 Plates – 96 wells x2)
- Sample Diluent (1 bottle – 175 mL)
- Dissociation Buffer (1 bottle – 27 mL)
- Conjugate Diluent (1 bottle – 27 mL)
- 10X Wash Solution (2 bottles – 100 mL)
- TMB Substrate (1 bottle – 27 mL)
- Stop Solution (1 bottle – 27 mL)
- Plate Sealers (1 package – 25 plate sealers)
Freezer Pack
- Negative Control Discs (1 vial – 10 discs)
- Calibrator Discs (1 vial – 15 discs)
- Low Positive Control Discs (1 vial – 15 discs)
- High Positive Control Discs (1 vial – 15 discs)
- 200X Conjugate Concentrate (1 vial – 180 μL)
Specifications
- Format: ELISA
- Sample Type: Dried Blood Spot (DBS)
- Test/Kit: 192 Tests
- Storage Temperature: 2-8°C (Refrigerated Pack) & -20°C (Freezer Pack)
Product Documentation
Ordering Information
- Catalog #: 92003
- Description: HIV-1 Limiting Antigen (LAg) Avidity DBS EIA Kit (192 Tests/Kit)
To place an order or to request additional information, please contact our support team